Apple and Masimo's patent and trade secret dispute has intensified through lawsuits as Apple defends its innovations and ...

A Delaware jury has found smartwatch maker Masimo guilty of infringing Apple's Apple Watch patents on health technology, but ...

Masimo's non-GAAP EPS of $0.98 topped internal guidance. Healthcare revenue surged by 11.5% year over year to $343.3 million. Litigation with Apple heighten financial uncertainties for the company ...

A federal jury ruled Friday that Masimo smartwatches infringed Apple patents, but Apple isn’t getting a big payday. Bloomberg Law reports that the company was only seeking the statutory minimum ...

Apple won the case, though was only awarded a nominal $250, which is the smallest amount it was possible for the court to order. In other words, yes Masimo did in infringe Apple’s patents, but there ...

Masimo MASI2.83%increase; green up pointing triangle said Joe Kiani, who previously informed the board of his decision to resign as chief executive, has been terminated by the company. Kiani’s ...

Apple and medical device company Masimo are currently embroiled in multiple legal battles, headlined by the ongoing fight over ...

Apple convinced a federal jury on Friday that health monitoring tech company Masimo’s smartwatches infringe two of its design patents. The jury, in Delaware, agreed with Apple that Masimo ...

Try Now>> See today’s best-performing stocks on TipRanks >> Read More on MASI: Masimo CorpShs NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

Piper Sandler raised the firm’s price target on Masimo (MASI) to $180 from $165 and keeps an Overweight rating on the shares. The firm notes the company announced Q3 revenue of $505M finished ...

Masimo (NASDAQ:MASI) is set to give its latest quarterly earnings report on Tuesday, 2024-11-05. Here's what investors need to know before the announcement. Analysts estimate that Masimo will ...